Polypharmacy Testing

A PROPRIETARY MEDICATION MANAGEMENT SOLUTION FOR BETTER SAFETY, ADHERENCE & OUTCOMES

Polypharmacy, the concurrent use of five or more medications, is common in older patients, patients with chronic illness and behavioral and mental health conditions, and during and after care transition.

Navis offers a proprietary polypharmacy testing solution that targets more than 120 drugs and metabolites for prescription and over-the-counter medications, including those commonly used for the treatment of chronic pain, psychiatric, cardiac, nephrology and diabetic conditions, to help identify potential nonadherence, contraindications and dangerous drug interactions.

Benefits of Polypharmacy Testing

DETECTS HIDDEN MEDICATION DISCREPANCIES

Screens for many common prescription and OTC medications, removing the reliance on incomplete or inaccurate patient medication disclosure and EHRs.

IMPROVED PATIENT SAFETY

Flags potential nonadherence, contraindications and drug-drug interactions that may lead to adverse events and supports deprescribing of inappropriate or unnecessary medications.

INTUITIVE RESULTS REPORT

Navis’ polypharmacy test results report is designed for easy navigation to find critical information quickly.

FAST TURNAROUND TIME

Test results within 24−48 hours.

Why Polypharmacy Testing?

Polypharmacy puts patients at increased risk of clinical deterioration, adverse drug events, drug-drug interactions, medication nonadherence, falls and hospital admissions. It also increases the possibility of “prescribing cascades” where additional medications are prescribed to treat misinterpreted ADRs. Drug interactions may also occur with many over-the-counter (OTC) and prescription medications.

Only 46% of patients tell their physician about any OTC medications they take¹

Patients who take 5 or more prescribed and/or OTC medications daily are 75% more likely to have an ADR²

Patients who take 5 or more prescribed medications have a 31% higher risk for mortality³

25% of older adults use a combination of 10 or more OTC and prescription medications daily²

30-day hospital readmission rates are >3x higher for patients with excessive polypharmacy⁴

¹ https://doi.org/10.1016/j.pec.2013.06.030 ² https://doi.org/10.1016/j.japh.2021.08.019 ³ https://doi.org/10.1038/s41598-020-75888-8 ⁴ https://www.icr-heart.com/article/impact-of-polypharmacy-on-hospital-readmission-rates-in-elderly-patients-with-multimorbidity-2460

Polypharmacy testing is a proprietary medication management solution ideal for clinicians who treat patients with complex chronic conditions that often contribute to polypharmacy, including:

Diabetes
Hypertension, Coronary Artery Disease (CAD), Other Cardiac Disease
Chronic Kidney Disease (CKD)
Hyperlipidemia
Cognitive Decline, Dementia
Respiratory
Chronic Pain
Mental Health ( ADHD, Bipolar Disorder, Anxiety, Depression)
Behavioral Health (Substance Use Disorder)

Polypharmacy testing also supports transitional care management of post-acute patients recently discharged to home health care to help prevent medication mismanagement and hospital readmissions.

Common drug types* tested for include:

ADHD
Anorectics
Anticonvulsants
Antidepressants
Antidiabetics
Antipsychotics
Anxiolytics / Sedatives
Cardiovascular
Cognitive / Dementia
Diuretics
Immunosuppressives
Migraine
Muscle Relaxants
Narcotics
NSAIDs
Over-the-Counter (OTC) and Recreational (Allergy, Cold, Pain, Caffeine, Alcohol, THC, Nicotine)

*Drug test availability may vary. Speak to a Navis Clinical Laboratories representative for more information.

Make prescribing safer. Make treatment faster. Make care more personal.
Navis Clinical Laboratories. Bringing precision medicine to the heart of health care.